1997-05-12
Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,D-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy
Publication
Publication
European Journal of Nuclear Medicine , Volume 24 - Issue 4 p. 368- 371
Additional Metadata | |
---|---|
, , , , | |
doi.org/10.1007/s002590050064, hdl.handle.net/1765/64878 | |
European Journal of Nuclear Medicine | |
Organisation | Department of Internal Medicine |
de Jong, M, Bakker, W.H, Krenning, E.P, Breeman, W.A.P, van der Pluijm, M, Bernard, B.F, … Mäcke, H.R. (1997). Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,D-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy. European Journal of Nuclear Medicine, 24(4), 368–371. doi:10.1007/s002590050064
|